Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Yan

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
JAMA Oncology|September 26, 2024
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular CarcinomaChi Leung Chiang, Kenneth Sik Kwan Chan, Keith Wan Hang Chiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 27, 2021
FasL<sup>+</sup> PD-L2<sup>+</sup> Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease ProgressionZhi-Guo Shan, Yong-Liang Zhao, Jin-Yu Zhang, et al.
Molecular Cancer Research : MCR|March 27, 2021
L-Plastin Promotes Gastric Cancer Growth and Metastasis in a <i>Helicobacter pylori cagA</i>-ERK-SP1-Dependent MannerYong-Sheng Teng, Wan-Yan Chen, Zong-Bao Yan, et al.
BMC Public Health|October 17, 2020
Association between economic development level and tuberculosis registered incidence in Shandong, ChinaQian-Yun Zhang, Dong-Mei Yang, Lin-Qing Cao, et al.
Practical Radiation Oncology|September 20, 2025
Long-Term Outcome of Stereotactically Designed Hypofractionated Image Guided Radiation Therapy in Large, Unresectable Hepatocellular CarcinomaNatalie Sean Man Wong, Francis Ann Shing Lee, Venus Wan Yan Lee, et al.
Clinical Science (London, England : 1979)|November 3, 2021
Helicobacter pylori-induced REDD1 modulates Th17 cell responses that contribute to gastritisZong-Bao Yan, Jin-Yu Zhang, Yi-Pin Lv, et al.
Journal of Asian Natural Products Research|March 12, 2025
Lifei Qingchang Tang attenuates acute lung injury <i>via</i> the NF-κB and MAPK signaling pathwaysQi-Fen Huang, Jia-Min Zeng, Yuan-Long Hu, et al.
Liver Cancer|May 17, 2024
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular CarcinomaChi Leung Chiang, Francis Ann Shing Lee, Kenneth Sik Kwan Chan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 27, 2025
Nrf2/STAT3-mediated activation of SLC6A3 underlies the neuroprotective effect of quercetin in ischemic strokeHuabao Cai, Meng-Yu Zhao, Cun-Zhi Wang, et al.
The Lancet. Gastroenterology & Hepatology|December 18, 2022
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trialChi Leung Chiang, Keith Wan Hang Chiu, Kenneth Sik Kwan Chan, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
JAMA Oncology|September 26, 2024
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular CarcinomaChi Leung Chiang, Kenneth Sik Kwan Chan, Keith Wan Hang Chiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 27, 2021
FasL<sup>+</sup> PD-L2<sup>+</sup> Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease ProgressionZhi-Guo Shan, Yong-Liang Zhao, Jin-Yu Zhang, et al.
Molecular Cancer Research : MCR|March 27, 2021
L-Plastin Promotes Gastric Cancer Growth and Metastasis in a <i>Helicobacter pylori cagA</i>-ERK-SP1-Dependent MannerYong-Sheng Teng, Wan-Yan Chen, Zong-Bao Yan, et al.
BMC Public Health|October 17, 2020
Association between economic development level and tuberculosis registered incidence in Shandong, ChinaQian-Yun Zhang, Dong-Mei Yang, Lin-Qing Cao, et al.
Practical Radiation Oncology|September 20, 2025
Long-Term Outcome of Stereotactically Designed Hypofractionated Image Guided Radiation Therapy in Large, Unresectable Hepatocellular CarcinomaNatalie Sean Man Wong, Francis Ann Shing Lee, Venus Wan Yan Lee, et al.
Clinical Science (London, England : 1979)|November 3, 2021
Helicobacter pylori-induced REDD1 modulates Th17 cell responses that contribute to gastritisZong-Bao Yan, Jin-Yu Zhang, Yi-Pin Lv, et al.
Journal of Asian Natural Products Research|March 12, 2025
Lifei Qingchang Tang attenuates acute lung injury <i>via</i> the NF-κB and MAPK signaling pathwaysQi-Fen Huang, Jia-Min Zeng, Yuan-Long Hu, et al.
Liver Cancer|May 17, 2024
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular CarcinomaChi Leung Chiang, Francis Ann Shing Lee, Kenneth Sik Kwan Chan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 27, 2025
Nrf2/STAT3-mediated activation of SLC6A3 underlies the neuroprotective effect of quercetin in ischemic strokeHuabao Cai, Meng-Yu Zhao, Cun-Zhi Wang, et al.
The Lancet. Gastroenterology & Hepatology|December 18, 2022
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trialChi Leung Chiang, Keith Wan Hang Chiu, Kenneth Sik Kwan Chan, et al.
Pageof 10